<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0">
<channel>
	<title>Veterans Claims for Service Connected Disability Compensation</title>
	<description>Veterans Claims for Service Connected Disability Compensation</description>
	<link>http://www.hadit.com/forums/index.php</link>
	<pubDate>Fri, 20 Nov 2009 19:04:47 -0500</pubDate>
	<ttl>60</ttl>
	<item>
		<title>Yesterday The Senate Passed S. 1963</title>
		<link>http://www.hadit.com/forums/index.php?showtopic=32618</link>
		<description><![CDATA[<!--fonto:Arial--><span style="font-family:Arial"><!--/fonto--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->[/size]<!--fontc--></span><!--/fontc--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Yesterday the Senate passed S. 1963, the "Caregiver and Veterans Omnibus Health Services Act of 2009", which would provide comprehensive new support to caregivers of severely disabled veterans and improve health care services for women veterans and all veterans who rely on the VA.<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->I wanted you to know that this important victory would not have been possible without the grassroots efforts of thousands of DAV members and supporters throughout the country.<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->With your help, DAV was able to play an important role in getting S. 1963 through the Senate and we will continue working with Congress until this legislation is enacted into law. <!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->For your perusal, I have included DAV's press release below. <br /><br />Thanks for all you have done.<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->------------------<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><b>FOR IMMEDIATE RELEASE<br /></b><!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->November 20, 2009<!--sizec--></span><!--/sizec--><b><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--></b> <br /><br /><b><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Senate Passes Major Veterans Legislation to Aid Caregivers, Women Veterans<!--sizec--></span><!--/sizec--></b><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->WASHINGTON, Nov. 20 - The Disabled American Veterans (DAV) applauds the U.S. Senate for unanimously approving S. 1963, "The Caregiver and Veterans Omnibus Health Services Act of 2009."<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->As passed, S. 1963 creates a comprehensive new program to support family caregivers of severely disabled veterans, and strengthens VA health care programs for women veterans, homeless veterans, veterans with mental health needs, and veterans suffering from traumatic brain injury.<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->"The Senate's overwhelming statement of support for this bill sends an unmistakable message that our government has an obligation to provide comprehensive support to family caregivers of severely wounded and disabled veterans," DAV National Commander Roberto Barrera said. "S. 1963 also contains landmark provisions that will help ensure that women veterans, who have played an increasingly essential role in our military, receive quality, timely and gender-appropriate health care services from the Department of Veterans Affairs (VA), equal in every respect to that afforded male veterans," Barrera said.<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->S. 1963 combines the content of two measures previously approved by the Senate Veterans' Affairs Committee, S. 252 and S. 801, into a single VA health care omnibus bill. Since the House of Representatives has already passed similar, but separate veterans health bills, the two bodies must now reach an agreement on identical legislation before it can be sent to the President for his approval.<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->"DAV looks forward to working together with the Senate and House Veterans' Affairs Committees and other interested veterans service organizations to develop the strongest veterans health care legislation we can to aid all veterans," Commander Barrera said. "In particular, we believe that disabled veterans from all eras could benefit from family caregiver support services and will work to see that the final legislation moves in that direction," he said.<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Commander Barrera expressed DAV's gratitude to several Senators who played leading roles in developing and moving the legislation successfully through the Senate.<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->"Senator Daniel Akaka, Chairman of the Senate's Committee on Veterans' Affairs, has been a tireless champion for veterans health care programs throughout his tenure, and his skillful work on S. 1963 was central to the Senate's approval," Barrera said. "A veteran himself, Chairman Akaka has proven to be a reliable and effective leader, always ready to stand up for our nation's veterans."<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->"Senator Richard Burr (N.C.), the Ranking Member of the Senate Veterans' Affairs Committee, worked in a truly bipartisan manner with the Chairman to help craft this legislation and then provide crucial leadership to help it overcome barriers that may otherwise have derailed it," Barrera said. "DAV applauds Senator Burr for putting the interests of veterans first."<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->"DAV also applauds the relentless efforts of Senator Patty Murray to enact legislation that will improve the lives of all veterans, especially women veterans. Senator Murray's landmark women veterans health care legislation was included within S. 1963, and her passionate advocacy for women veterans has been crucial throughout this process," Barrera said.<!--sizec--></span><!--/sizec--><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->The 1.2 million-member Disabled American Veterans, a non-profit organization founded in 1920 and chartered by the U.S. Congress in 1932, represents this nation's disabled veterans. It is dedicated to a single purpose: building better lives for our nation's disabled veterans and their families. More information is available at <!--sizec--></span><!--/sizec--><a href="http://capwiz.com/dav/utr/1/BKPULQUOTM/LRYELQUZKS/4294034851" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->www.dav.org<!--sizec--></span><!--/sizec--></a><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> <!--sizec--></span><!--/sizec-->]]></description>
		<pubDate>Fri, 20 Nov 2009 18:44:18 -0500</pubDate>
		<guid>http://www.hadit.com/forums/index.php?showtopic=32618</guid>
	</item>
	<item>
		<title>Social Security, Compassionate Allowances</title>
		<link>http://www.hadit.com/forums/index.php?showtopic=32617</link>
		<description><![CDATA[<a href="http://www.socialsecurity.gov/compassionateallowances/" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->http://www.socialsecurity.gov/compassionateallowances/<!--sizec--></span><!--/sizec--></a><br /><br /><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Social Security has an obligation to provide benefits quickly to applicants whose medical conditions are so serious that their conditions obviously meet disability standards. <br /><br />Compassionate allowances are a way of quickly identifying diseases and other medical conditions that invariably qualify under the Listing of Impairments based on minimal objective medical information. Compassionate allowances allow Social Security to quickly target the most obviously disabled individuals for allowances based on objective medical information that we can obtain quickly.<br /><br />Commissioner Astrue has held four Compassionate Allowance public outreach hearings. The hearings were on rare diseases, cancers, traumatic brain injury (TBI) and stroke, and early-onset Alzheimer's disease and related dementias. The Commissioner will hold the fifth public outreach hearing on schizophrenia in November 2009. The hearing will take place in San Francisco, California.<br /><br />The initial list of Compassionate Allowance conditions was developed as a result of information received at public outreach hearings, public comment on an Advance Notice of Proposed Rulemaking, comments received from the Social Security and Disability Determination Service communities, and the counsel of medical and scientific experts. Also, we considered which conditions are most likely to meet our current definition of disability.<br /><br />A modest 50 conditions were selected for the initiative's rollout. The list which follows will expand over time.<br /><br /><!--sizec--></span><!--/sizec--><a href="https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022000!opendocument" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Additional information about how compassionate allowances are processed<!--sizec--></span><!--/sizec--></a><br /><br /><a href="https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022000!opendocument" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->https://secure.ssa.gov/apps10/poms.nsf/lnx/...33;opendocument<!--sizec--></span><!--/sizec--></a><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--> <br /><br /><!--sizec--></span><!--/sizec--><a href="http://www.socialsecurity.gov/compassionateallowances/conditions.htm" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Initial List of Compassionate Allowance Conditions<!--sizec--></span><!--/sizec--></a><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><b>List of Conditions</b><br /><br /><br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->1<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Acute Leukemia<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->2<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Adrenal Cancer - with distant metastases or inoperable, unresectable or recurrent<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->3<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Alexander Disease (ALX) - Neonatal and Infantile<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->4<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Amyotrophic Lateral Sclerosis (ALS)<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->5<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Anaplastic Adrenal Cancer - with distant metastases or inoperable, unresectable or recurrent<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->6<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Astrocytoma - Grade III and IV<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->7<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Bladder Cancer - with distant metastases or inoperable or unresectable<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->8<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Bone Cancer - with distant metastases or inoperable or unresectable<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->9<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Breast Cancer - with distant metastases or inoperable or unresectable<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->10<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Canavan Disease (CD)<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->11<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Cerebro Oculo Facio Skeletal (COFS) Syndrome<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->12<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Chronic Myelogenous Leukemia (CML) - Blast Phase<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->13<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Creutzfeldt-Jakob Disease (CJD) - Adult<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->14<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Ependymoblastoma (Child Brain Tumor)<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->15<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Esophageal Cancer<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->16<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Farber's Disease (FD) - Infantile<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->17<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Friedreichs Ataxia (FRDA)<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->18<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Frontotemporal Dementia (FTD), Picks Disease -Type A - Adult<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->19<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Gallbladder Cancer<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->20<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Gaucher Disease (GD) - Type 2<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->21<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Glioblastoma Multiforme (Brain Tumor)<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->22<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Head and Neck Cancers - with distant metastasis or inoperable or uresectable<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->23<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Infantile Neuroaxonal Dystrophy (INAD)<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->24<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Inflammatory Breast Cancer (IBC)<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->25<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Kidney Cancer - inoperable or unresectable<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->26<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Krabbe Disease (KD) - Infantile<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->27<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Large Intestine Cancer - with distant metastasis or inoperable, unresectable or recurrent<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->28<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Lesch-Nyhan Syndrome (LNS)<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->29<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Liver Cancer<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->30<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Mantle Cell Lymphoma (MCL)<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->31<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Metachromatic Leukodystrophy (MLD) - Late Infantile<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->32<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Niemann-Pick Disease (NPD) - Type A<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->33<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Non-Small Cell Lung Cancer - with metastases to or beyond the hilar nodes or inoperable, unresectable or recurrent<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->34<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Ornithine Transcarbamylase (OTC) Deficiency<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->35<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Osteogenesis Imperfecta (OI) - Type II<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->36<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Ovarian Cancer - with distant metastases or inoperable or unresectable<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->37<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Pancreatic Cancer<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->38<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Peritoneal Mesothelioma<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->39<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Pleural Mesothelioma<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->40<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Pompe Disease - Infantile<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->41<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Rett (RTT) Syndrome<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->42<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Salivary Tumors<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->43<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Sandhoff Disease<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->44<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Small Cell Cancer (of the Large Intestine, Ovary, Prostate, or Uterus)<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->45<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Small Cell Lung Cancer<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->46<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Small Intestine Cancer - with distant metastases or inoperable, unresectable or recurrent<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->47<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Spinal Muscular Atrophy (SMA) - Types 0 And 1<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->48<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Stomach Cancer - with distant metastases or inoperable, unresectable or recurrent<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->49<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Thyroid Cancer<br /><br /><!--sizec--></span><!--/sizec--><div align='center'><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->50<!--sizec--></span><!--/sizec--></div><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Ureter Cancer - with distant metastases or inoperable, unresectable or recurrent<br /><br /><br /><br /><br /><br />"Keep on, Keepin' on"<br />Dan Cedusky, Champaign IL "Colonel Dan"<br />See my web site at:<br /><!--sizec--></span><!--/sizec--><a href="http://www.angelfire.com/il2/VeteranIssues/" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->http://www.angelfire.com/il2/VeteranIssues/<!--sizec--></span><!--/sizec--></a><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--> <!--sizec--></span><!--/sizec-->]]></description>
		<pubDate>Fri, 20 Nov 2009 18:38:13 -0500</pubDate>
		<guid>http://www.hadit.com/forums/index.php?showtopic=32617</guid>
	</item>
	<item>
		<title><![CDATA[New Denver Vamc, Doesn't Have Ptsd Program?  That Can't Be Right]]></title>
		<link>http://www.hadit.com/forums/index.php?showtopic=32616</link>
		<description><![CDATA[<br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->[/size]<b><a href="http://www.thedenverchannel.com/news/21301540/detail.html" target="_blank"><br />[b]</a><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->New Denver VAMC, Doesn't have PTSD Program?  That can't be right<br /><br /><br /><!--sizec--></span><!--/sizec--><a href="http://www.thedenverchannel.com/news/21301540/detail.html" target="_blank"></b><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->http://www.thedenverchannel.com/news/21301540/detail.html<!--sizec--></span><!--/sizec--></a>[/b]<br /><br /><b><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--></b><br /><br /><b>DENVER -- </b>When officials broke ground on the new $800 million VA Medical Center, many veterans assumed that a residential treatment center for those suffering from Post Traumatic Stress Disorder would be built in the new hospital. <br /><br />But several were surprised to learn this month that the hefty price tag does not include the PTSD treatment center. <br /><br />"This is beyond comprehension," said Rep. Mike Coffman, who is himself a veteran of the gulf war and of the war in Iraq. <br /><br />VA officials told 7NEWS that "major construction funds" can’t be spent on the residential treatment facility, but that the facility will be built. <br /><br />"The PTSD residential program is a crown jewel of VA in eastern Colorado," said Lynette Roff, director of the VA’s eastern Colorado health care system. "We are very committed to making sure it is included in our new facility and that it continues to grow." <br /><br />Roff said the VA has applied for separate funds for a stand alone facility which will be constructed just to the north of the new hospital. <br /><br />She said the $9.5 million PTSD Center will open about the same time as the new hospital. <br /><br />"We have lots of time between now and 2013 or 2014 when we activate the hospital to make that residential treatment facility become a reality," Roff said. <br /><br />That's good news for Chuck Douglas and Paul A. Hernandez, both Vietnam veterans who went through the program at the existing VA hospital. <br /><br />“It has been immensely helpful to me,” Douglas said. “I can’t give enough credit to the staff.” <br /><br />“I didn’t realize I had issues,” Hernandez said. “People with PTSD isolate themselves. They don’t talk to other people. You waste your life away basically.” <br /><br />"We don’t want the new center for us," the two vets said. "We want it for the servicemen and women who are coming home from Iraq and Afghanistan." <br /><br />Coffman said he’s going to see if the funding law needs to be changed. <br /><br />"For them to have failed to incorporate this into their original plans makes me question a lot about what else is in the plan or isn’t in the plan," the congressman said.<br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Also see:<!--sizec--></span><!--/sizec--><br /><br /><a href="http://www.chieftain.com/articles/2009/10/25/.&#46;&#46;/doc4ae3885a0c061712657647.txt" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->www.chieftain.com/articles/2009/10/25/.&#46;&#46;/doc4ae3885a0c061712657647.txt<!--sizec--></span><!--/sizec--></a><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--> <!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--><br /><br />1.<!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->    <!--sizec--></span><!--/sizec--><b>DENVER</b> -- When officials broke ground on the <b>new</b> $800 million <b>VA</b> Medical Center, <b>...</b> month that the hefty price tag does <b>not include the PTSD</b> treatment center. <b>...</b> “The <b>PTSD residential program</b> is a crown jewel of <b>VA</b> in eastern Colorado,” said <b>...</b> which will be constructed just to the north of the <b>new hospital</b>. <b>...</b><br /><i>woundedtimes.blogspot.com/.&#46;&#46;/how-many-more-<b>veterans</b>-will-die-between.html </i><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><!--sizec--></span><!--/sizec--> [size="3"]"Keep on, Keepin' on"<br />Dan Cedusky, Champaign IL "Colonel Dan"<br />See my web site at:<br /><!--sizec--></span><!--/sizec--><a href="http://www.angelfire.com/il2/VeteranIssues/" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->http://www.angelfire.com/il2/VeteranIssues/<!--sizec--></span><!--/sizec--></a>]]></description>
		<pubDate>Fri, 20 Nov 2009 18:35:05 -0500</pubDate>
		<guid>http://www.hadit.com/forums/index.php?showtopic=32616</guid>
	</item>
	<item>
		<title>Iris</title>
		<link>http://www.hadit.com/forums/index.php?showtopic=32615</link>
		<description><![CDATA[My last C&P exam was 10 September 2009.  Then I had a letter from Qu Te Ce asking me to go back for an Upper GI test.  The test was 09 October 2009.  I think that I shouldn't need anymore C&P exams, or anyother test ordered.  <br /><br />If I ask on the status with an IRIS, will it delay the claim?   "I don't want to loose my place in line"]]></description>
		<pubDate>Fri, 20 Nov 2009 16:22:20 -0500</pubDate>
		<guid>http://www.hadit.com/forums/index.php?showtopic=32615</guid>
	</item>
	<item>
		<title>Vbm And</title>
		<link>http://www.hadit.com/forums/index.php?showtopic=32614</link>
		<description><![CDATA[<a href="http://www.nvlsp.org/Information/ArticleLibrary/FederalCircuitCourt/index.htm" target="_blank">http://www.nvlsp.org/Information/ArticleLi...Court/index.htm</a><br /><br />This is a very nice 'comment' from the court as to the value of this extraordinary legal text-the VBM from NVLSP.<br /><br />I know many question the cost and value of the VBM but I would have gotten no where with my claims if I did not have it-been getting it since 1991.<br /><br />NVLSP is non profit and their help to vets is Pro Bono.]]></description>
		<pubDate>Fri, 20 Nov 2009 15:15:58 -0500</pubDate>
		<guid>http://www.hadit.com/forums/index.php?showtopic=32614</guid>
	</item>
	<item>
		<title>Agent Orange Equity Act</title>
		<link>http://www.hadit.com/forums/index.php?showtopic=32609</link>
		<description><![CDATA[<!--fonto:Arial--><span style="font-family:Arial"><!--/fonto--><!--sizeo:2--><span style="font-size:10pt;line-height:100%"><!--/sizeo--><!--coloro:#000000--><span style="color:#000000"><!--/coloro--> <i><!--sizeo:5--><span style="font-size:18pt;line-height:100%"><!--/sizeo-->NEWS FROM…<!--sizec--></span><!--/sizec--></i><br /><br /> <!--sizeo:5--><span style="font-size:18pt;line-height:100%"><!--/sizeo-->CHAIRMAN BOB  FILNER<!--sizec--></span><!--/sizec--><br /><br /> <!--sizeo:5--><span style="font-size:18pt;line-height:100%"><!--/sizeo-->HOUSE COMMITTEE ON VETERANS’  AFFAIRS<!--sizec--></span><!--/sizec--><br /><br /> <br /><br /> FOR IMMEDIATE RELEASE: November 20, 2009<br /><br /> Contact Kristal DeKleer at (202) 225-9756  <br /><br /> <a href="http://veterans.house.gov/" target="_blank"><u><!--coloro:#0000ff--><span style="color:#0000ff"><!--/coloro-->http://veterans.house.gov<!--colorc--></span><!--/colorc--></u></a><br /><br /> <br /><br /> <b><i><!--sizeo:4--><span style="font-size:14pt;line-height:100%"><!--/sizeo-->Washington, D.C.<!--sizec--></span><!--/sizec--></i></b><i> <!--sizeo:4--><span style="font-size:14pt;line-height:100%"><!--/sizeo-->– House Veterans’  Affairs Committee Chairman Bob Filner (D-CA) released the following statement in  response to H.R. 2254, The Agent Orange Equity Act of 2009, reaching 200+  cosponsors:     <!--sizec--></span><!--/sizec--></i><br /><br /> <br /><br /> <b><!--sizeo:6--><span style="font-size:24pt;line-height:100%"><!--/sizeo-->More  than 200 Members of Congress Agree: Agent Orange Veterans Deserve Compensation  for Their Sacrifice!!<!--sizec--></span><!--/sizec--></b><br /><br /> <br /><br /> “Republicans and Democrats alike have joined  together to stand up for Agent Orange veterans.  More than 200 Members of the  House of Representatives have added their support for H.R. 2254, a bill to  expand the eligibility for presumptive conditions to all combat veterans of the  Vietnam War, regardless of where they served.  Current law requires VA to  provide care for service members exposed to Agent Orange by virtue of their  ‘boots on the ground,’ but ignores veterans that served in the blue waters and  the blue skies of Vietnam.  H.R. 2254 will provide veterans with benefits based  on their exposure to Agent Orange regardless of an arbitrary geographic line or  location.  These are benefits that they have earned, yet the Department of  Veterans’ Affairs illogically refuses to acknowledge them.<br /><br /> “Time is running out for these Vietnam veterans.  Many are dying from their Agent Orange related diseases, uncompensated for their  sacrifice. If, as a result of service, a veteran was exposed to Agent Orange and  it has resulted in failing health, this country has a moral obligation to care  for each veteran the way we promised we would. And as a country at war, we must  prove that we will be there for all of our veterans, no matter when they serve.  <br /><br /> “There is still a chance for America to meet its  obligations to these estimated 800,000 noble veterans.  The courts have turned  their backs on our veterans, but I believe this Congress will not allow veterans  to be cheated of their earned benefits.  I would like to thank the more than 200  Members of the House who have bravely joined the fight to stand up for the  rights of Agent Orange veterans.  I also urge Senators to cosponsor S. 1939,  Senator Gillibrand’s companion legislation."<br /><br /> <br /><br /> <!--fonto:Times--><span style="font-family:Times"><!--/fonto--><!--coloro:#000000--><span style="color:#000000"><!--/coloro-->###<!--colorc--></span><!--/colorc--><!--fontc--></span><!--/fontc--><br /><br /> <a href="http://veterans.house.gov/dear_colleague/H.R.2254DearColleague.pdf" target="_blank">http://veterans.house.gov/dear_colleague/H...arColleague.pdf</a><!--fonto:Times--><span style="font-family:Times"><!--/fonto--><!--coloro:#000000--><span style="color:#000000"><!--/coloro--><br /><!--colorc--></span><!--/colorc--><!--fontc--></span><!--/fontc--><br /><br /><!--colorc--></span><!--/colorc--><!--sizec--></span><!--/sizec--><!--fontc--></span><!--/fontc-->]]></description>
		<pubDate>Fri, 20 Nov 2009 13:55:21 -0500</pubDate>
		<guid>http://www.hadit.com/forums/index.php?showtopic=32609</guid>
	</item>
	<item>
		<title>Question About Service Connection</title>
		<link>http://www.hadit.com/forums/index.php?showtopic=32603</link>
		<description><![CDATA[I am assisting a fellow marine that was sexually assulted by his drill instructor in Bootcamp in the 1980's.  He was 17 when it accured and did not report it.  It has caused him some serious issues over the years and he has been seeking treatment from the VA for the last few months.  He was evaluated and was given a diagnosis of PTSD, Chronic, Severe, and has an axis score of 45, they have proscribed medication for treatment--here is the question how does he get this listed SERVICE CONNECTEDsince he did not report it?  He opened a claim for PTSD already and they are asking for supportive evidence??? Any help would be appreicated.]]></description>
		<pubDate>Fri, 20 Nov 2009 11:38:37 -0500</pubDate>
		<guid>http://www.hadit.com/forums/index.php?showtopic=32603</guid>
	</item>
	<item>
		<title>Scar Question On Claim</title>
		<link>http://www.hadit.com/forums/index.php?showtopic=32602</link>
		<description><![CDATA[Has anyone here have a percentage for scars,  I have a 3 inch scar on my left shin. Monday i have a C&P for the scar, i am currently 90% and need would like to go to 100 % any ideas about the claim process for scars....]]></description>
		<pubDate>Fri, 20 Nov 2009 11:03:31 -0500</pubDate>
		<guid>http://www.hadit.com/forums/index.php?showtopic=32602</guid>
	</item>
	<item>
		<title>Gulf War Veterans 1990-91 Demand Real Diagnostic Testing And Action Now</title>
		<link>http://www.hadit.com/forums/index.php?showtopic=32598</link>
		<description><![CDATA[<!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><b><!--coloro:#363636--><span style="color:#363636"><!--/coloro-->Gulf War Veterans 1990-91 Demand Real Diagnostic Testing and Action NOW<br /><br /><!--colorc--></span><!--/colorc--></b>Posted on November 18, 2009 by <a href="mailto:dsnurse1@yahoo.com">dsnurse</a> <br /><br /><!--sizec--></span><!--/sizec--><b><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->The Controversy continues: IS THE VA Using the Best Test?<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Gulf War Veterans 1990-91 Demand Real Diagnostic Testing and Action NOW<!--sizec--></span><!--/sizec--><br /></b><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->I fully anticipate an attack but this article that follows is well written and addresses one issue. That issue is Science being corrupted and how it impacts veterans. The veterans of Gulf War 1990-91 are ill and not getting better. In fact I have the obits I am working on for October and November. I know I am not getting all the obits but these show a small picture of the impact and losses. How many of these went to the VA at all, I do not know. How many are rated by the VA, I do not know. I do know we the veterans are not getting all the facts. I can guarantee you that we are not getting the tests that are mentioned. Would the tests spoken about lead to more truth? Why aren't these test being used in research, I don't have that answer but could guess. The gulf war veterans of 1990-91 simply went and did their duty and came home ill and have been seeking answers and help. WE have no choice but to continue to seek answers in biomarkers, diagnostic testing, proactive care to include active screening for all diseases and diagnosis, and to push for treatment! And to demand compensation and all assistance, we went healthy and came back ill! WE need help rapidly just as much as OIF/OEF/Koskovo/Vietnam Veterans/Agent Orange/ WWII vets. WE need assistance that is being offered to OIF/OEF veterans in new legislation but we are not being covered. Why do sick and ill veterans have to battle every step of the way to get any help? We are the unseen casualties and the uncounted casualties.<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Depleted Uranium and the Medical Mismanagement of Gulf War Veterans<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->by Paul Zimmerman<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->The United States insists that weapons containing depleted uranium pose no health hazards to exposed populations. This charade persists because an artful propaganda matrix has infiltrated and corrupted certain aspects of the radiation and biological sciences. The facts which follow will introduce how our debilitated veterans are being misinformed of the possible role played by uranium in their illnesses.<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->1. Within the medical system of the Veterans Administration, veterans are misled into believing that no medical test exists that can determine DU contamination. This stance was echoed in a 2006 study by the Institute of Medicine, lauded as "...the authoritative word on Gulf War Illness" (1). In the preface of the IOM's definitive study, this quote appears: "Although there is a blood test that can provide an indication of exposure to Agent Orange and dioxin that occurred many years ago, there is not (sic) biological measure that can be employed today to assess exposures during the Gulf War" (2).<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->This statement is a lie. A protocol does exist which can determine depleted uranium contamination years after the exposure event. The methodology was published in 2002 by Durakovic, Horan and Dietz (3). Essentially it involves collecting a 24-hour urine sample and analyzing the uranium content by means of multicollector, inductively coupled plasma ionization mass spectrometry. By this means the relative concentration of the different uranium isotopes can be measured. This information can then be used to determine whether or not the test subject was contaminated with DU. This test has been reproduced by a number of research groups around the world and has been confirmed as the state-of-the-art means of accurately determining DU exposure. The Veterans Administration ignores this scientific breakthrough and does not offer it to veterans attempting to come to terms with the cause of their illnesses. <!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->2. The US government ardently wishes to convince the public that the only battlefield hazard posed by DU munitions is shrapnel injuries. Again, the Institute of Medicine study succinctly states this position: "...it is now understood that retention of DU-containing embedded shrapnel is the major source of increased DU exposure in military personnel." This too is a lie. Its purpose is to draw attention away from the inhalation pathway. In the study by Durakovic et al. mentioned above, 27 veterans were studied. All presented complex, nonspecific symptoms of Gulf War Illness. None of them had suffered shrapnel injury. Among this cohort, 14 were found to have been contaminated with depleted uranium. It is important to note that this test was conducted nine years after the Gulf War, demonstrating the long residency time of inhaled uranium and the ability to identify such contamination years after the exposure event. <!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->3. According to conventional wisdom, there are two vectors to uranium's toxicity: it is radioactive and it is a heavy metal capable of producing adverse chemical effects. These two phenomenon are usually treated separately despite the fact that abundant research has proven that the two work synergistically, each enhancing the deleterious effects of the other. Uranium's radioactivity is rejected out of hand as hazardous because the "dose" of radiation likely to be absorbed on the contaminated battlefield is too low to produce cancer. Cancer? Why does cancer enter the discussion of the unexplained illness of Gulf War veterans? Unbeknownst to most people, the current science of radiation safety confines itself to cancer causation. This is a sophisticated ruse that has held sway over radiation protection for half a century. There exists a large body of research on noncancerous effects of radiation that is ignored by the international radiation protection community and the Veterans Administration. [A complete explanation can be found in (4) in the bibliography]. <!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->As for uranium's chemical toxicity, typical acute exposure events prior to the first Gulf War, such as with uranium miners, led to the determination that the kidney was the organ most susceptible to damage. However, battlefield exposure has no corollary to any other type of uranium exposure and, as a consequence, may produce unique physiological effects. In no other circumstances do humans inhale aerosolized micro- and nano-sized particles of highly insoluble ceramic uranium-bearing material. Innovative research is urgently needed to confirm if other types of injury may be initiated in the contaminated individual that bypasses observable damage to the kidney. (See discussion below). <!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->4. The first Gulf War ignited a renewed interest in the toxicology of uranium. Numerous laboratory studies have documented that uranium is genotoxic (capable of damaging DNA), cytotoxic (poisonous to cells), mutagenic (capable of inducing mutations), teratogenic (capable of interfering with normal embryonic development) and neurotoxic (capable of harming nerve tissue). This research has yet to dislodge the stale mantra that uranium is only capable of causing cancer or kidney damage. [For an extensive review of recent research on the toxicology of uranium, see (4)].<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->5. Here's an example of blatant medical fraud. A veteran suffering from the undiagnosed illness commonly referred to as Gulf War Syndrome, goes to his doctor concerned that uranium exposure may have been a factor in his deteriorating condition. In response, the physician orders a test to measure the total concentration of uranium in a 24-hour urine sample. (This is an entirely different test from the one described earlier.) When the test results return from the lab, the GI is informed that the amount of uranium in his urine is within the normal range. Uranium contamination is not a problem. What he is not told is that this was a foregone conclusion. Why? Because he was given the wrong diagnostic test!<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->In accidents where people absorb into their bodies an abnormal amount of uranium, the soluble portion relatively rapidly enters the blood, is transported to the kidneys and is then excreted. During this period, measured in days to weeks, the uranium concentration in the urine will be elevated while the body efficiently goes about ridding itself of excess uranium. Measurement of total uranium in urine during this time will demonstrate abnormally high levels which can be used to determine if kidney damage is a possible concern. Similarly, a veteran injured by shrapnel will show an elevated concentration of uranium in his urine for years as uranium slowly dissolves from the metal fragments in his body. In the case of inhalation exposure, measurement of total uranium would be elevated only if measured on the battlefield soon after exposure while the soluble fraction of uranium is being eliminated from the body. But conducted years after exposure, the test would provide no useful information because uranium levels would have returned to within the normal range. What's not being addressed is the fate of the insoluble portion of the absorbed uranium. This uranium dissolves very slowly, over a period of years. While this is taking place, the total concentration of uranium in the urine may never rise above the normal range. If a veteran wants to know whether he is carrying depleted uranium in his body years after exposure, he requires the proper diagnostic test, the one mentioned in #1 above. <!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->5. The war is Bosnia was fought between March 1992 and November 1995. In its aftermath, soldiers serving in the former Yugoslavian army, staffers of humanitarian missions and Yugoslavian residents began manifesting symptoms of some unidentified illness similar to that suffered by US soldiers who served in the Gulf. Belatedly, NATO announced in 2000 that munitions containing depleted uranium had been fired on the Bosnian battlefields. This revelation was groundbreaking. The Bosnian theater contained none of the risk factors for Gulf War Illness that veterans were exposed to who served in Iraq and Kuwait such as oil well fires, vaccines for anthrax or botulinum toxins, Iraqi chemical and biological warfare agents, etc. The only factor that linked the two theaters together were DU munitions. <!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Using an innovative technique of electronic microscopy, Antonietta Gatti and Stephano Montanari analyzed tissue samples taken from those suffering so-called Balkan War Syndrome (5). Every tissue sample and lymph node that was examined contained spherical, combustion-derived metal-alloyed microparticles and nanoparticles. To confirm an environmental origin of this debris, the researchers noted that particles found in the tissues of diseased soldiers and civilians were "mutually compatible" with those found on the ground in the territories where battles had been fought and where the pathologies were contracted. <!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->This avenue of investigation reveals a third vector of DU's toxicity which acts synergistically with DU's radiation and chemical effects. Nanoparticles have recently received a great deal of attention due the numerous proposed applications of nanotechnology, the use of materials smaller than 100 nanometers (0.1 microns). Nanoparticles have been shown to exhibit many unusual properties. They possess the ability to pass directly through certain tissue types, travel along neurons, escape filtration from the blood by the spleen and the liver, and avoid immune system detection by macrophages. These unusual characteristics give nanoparticles ready access to all tissues of the body. While circulating through the body, their surface chemistry provides a platform for ongoing heavy metal interactions with the body's molecular makeup. Thus, insoluble uranium nanoparticles represent point sources for chronic chemical and radiological poisoning to the body's interior. In addition, nanoparticles of many different compositions have been implicated in initiating inflammation, oxidative stress and gene activation.<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->With over 100,000 Gulf War veterans ill with an undiagnosed illness, one would think that the work of Gatti and Montanari would have stimulated medical follow-up among researchers sincerely interested in exploring the origins of Gulf War Illness. However, their work has so far remained ignored by the Veterans Administration.<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->6. On August 20, 2007, the Discovery Channel aired an episode in its series Conspiracy Test entitled "Gulf War Illness". During the program, the results of research undertaken at the Molecular Medicine and Genetics Lab at Wayne State University were presented. In a preliminary study supervised by Dr. Henry Heng, blood samples were collected from five veterans of the 1991 Gulf War who were suffering symptoms of the undiagnosed illness they had contracted while in military service. All had previously tested positive for the presence of DU in their urine and none had served in any area of Iraq where possible exposure to chemical warfare agents might have occurred as a result of the destruction of weapon caches at Khamisiyah. Using spectral karyotyping (SKY), Heng and his graduate students imaged and analyzed the chromosome structure of blood cells in each of the veterans. What Heng and his colleagues found using this technique was startling. The karyotype of each of the veterans clearly displayed significant levels of chromosome damage. According to Heng, the damage widely exceeded that observed in cancer patients. Translocations, broken chromosomes, centromere displacements and aneuploidy (a gain or loss in the number of chromosomes) were observed. According to Heng, the chromosome aberrations observed were typical of the type of damage produced by radiation. This is another avenue of investigation ignored by VA. <!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->7. In 2003, Heike Schröder and her research associates published a study of 16 British Gulf War and Balkan War veterans who suspected that they had been exposed to depleted uranium. When compared to suitable controls, the study group demonstrated a statistically significant increase in the frequency of dicentric chromosomes and centric-ring chromosomes in peripheral lymphocytes (6). (These aberrantly shaped chromosomes are created when two double-strand breaks in DNA are improperly repaired, either between the DNA from two separate chromosomes or within the DNA of a single chromosome. The elevated occurrence of these in individuals serves as a biological indicator of exposure to ionizing radiation.)<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->The findings of Schröder and her colleagues are extremely significant. The observed chromosome aberration frequency they observed should not have been occurring at the "dose" delivered by battlefield DU. According to the authors: "However, as dicentric chromosomes are reliable indicators of ionizing radiation, our findings contradict official releases from the IAEA, the WHO, the MOD and the DOE, stating that the radiotoxicity of DU would be negligible" (7). A further bewildering discovery was that the observed chromosome aberrations should not have been so prevalent 10 years after exposure, which was when the veterans in this study were tested. Schröder offered the observation that soluble DU would have been flushed from the bodies of test subjects relatively soon after exposure. Further, the biological half-life of dicentric chromosomes is 3.5 years. As a consequence, the observed chromosome aberrations could not have been produced at the time of the exposure event. So how were they produced? Schröder proposed that the chromosome aberrations were a manifestation of ongoing damage to the body's interior produced by the radiation emitted from insoluble particles that were lodged in the body since the moment they were absorbed on the contaminated battlefield.<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->The scientific research mentioned above clearly suggests that depleted uranium is a factor in the undiagnosed illness suffered by veterans. Yet numerous publications from the world's guardian institutions continue to proclaim that this is impossible. The VA has aligned itself with this political propaganda and, in the process, makes a mockery of science.<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->To conclude, the Veterans Administration is being lackadaisical at best, criminally negligent at worst, in its treatment of veterans suffering from symptoms of so-called Gulf War Illness. Valuable avenues of research are being intentionally ignored because they raise disturbing questions of the impact to health from radioactive material released into the environment. Rather than throw a disparaging light on cherished weapon systems, our cherished veterans are being abused by an uncaring medical system..<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Bibliography<!--sizec--></span><!--/sizec--><br /><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->1. Sartin J.S. "Gulf War Syndrome: The Final Chapter?" Mayo Clinic Proceedings. 2006; 81(11):1425-1426.<br />2. Institute of Medicine. Committee on Gulf War and Health. A Review of the Medical Literature Relative to the Gulf War Veterans' Health. Gulf War and Health. Volume 4: Health Effects of Serving in the Gulf War. Washington, DC: National Academies Press; 2006.<br />3. Durakovic A., Horan P., Dietz L. "The Quantitative Analysis of Depleted Uranium Isotopes in British, Canadian, and U.S. Gulf War Veterans". Military Medicine. 2002; 167(8):620-627.<br />4. Zimmerman P. A Primer in the Art of Deception: The Cult of Nuclearists, Uranium Weapons and Fraudulent Science. August, 2009. <!--sizec--></span><!--/sizec--><a href="http://www.du-deceptions.com/" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->www.du-deceptions.com<!--sizec--></span><!--/sizec--></a><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->5. Gatti A.M., Montanari S. "So-called Balkan Syndrome: A Bioengineering Approach". Emilia, Italy: Laboratory of Biomaterials of the University of Modena and Reggio; February 2004. <!--sizec--></span><!--/sizec--><a href="http://www.idust.net/Docs/Nanoparticles01" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->http://www.idust.net/Docs/Nanoparticles01<!--sizec--></span><!--/sizec--></a><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->6. Schröder H. Presentation at the World Uranium Weapons Conference. October 16-19, 2003. University of Hamburg, Germany. <!--sizec--></span><!--/sizec--><a href="http://www.traprockpeace.org/depleted_uranium_hamburg03.html" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->http://www.traprockpeace.org/depleted_uranium_hamburg03.html<!--sizec--></span><!--/sizec--></a><br /><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->7. Schröder H., Heimers A., Frentzel-Beyme R., Schott A., Hoffmann W. Chromosome Aberration Analysis in Peripheral Lymphocytes of Gulf War and Balkans War Veterans. Radiation Protection Dosimetry. 2003; 103(3):211-219. <!--sizec--></span><!--/sizec--><br /><br /><a href="http://www.veteranstoday.com/article9445" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->http://www.veteranstoday.com/article9445<!--sizec--></span><!--/sizec--></a>]]></description>
		<pubDate>Fri, 20 Nov 2009 03:20:32 -0500</pubDate>
		<guid>http://www.hadit.com/forums/index.php?showtopic=32598</guid>
	</item>
	<item>
		<title><![CDATA["ominous" Phone Message Tells Veterans About Education Claims Backlog.]]></title>
		<link>http://www.hadit.com/forums/index.php?showtopic=32597</link>
		<description><![CDATA[<!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><b>"Ominous" Phone Message Tells Veterans About Education Claims Backlog. <br /><br /></b>Northern Illinois University's <!--sizec--></span><!--/sizec--><a href="http://www.northernstar.info/article/9236/" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Northern Star<!--sizec--></span><!--/sizec--></a><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--> (11/19, Lawe) reports, "Student-veterans seeking a solution to their money problems from...Veterans Affairs over the phone receive an ominous message. 'The Veterans Administration is receiving an unprecedented number of education claims, and as a result it is temporarily taking longer than usual to process claims,' a recorded message states before an options menu is even reached." The "message...is advising veterans to wait 10 to 12 weeks for their claims to process. The backup is due to a new" GI Bill "being implemented by the VA, which came into effect Aug. 1." The Northern Star adds, "'I think that the VA did not put enough people on this issue,' said J.D. Kammes, president of the NIU Veterans Club."<br /><br />     <!--sizec--></span><!--/sizec--><a href="http://" target="_blank"></a><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--><b><i>Backlog Causing Financial Problems For </i></b><b><i>Iraq</i></b><b><i> Vet.<br /><br /></i></b><b><i> </i></b>Massachusetts' <!--sizec--></span><!--/sizec--><a href="http://www.southcoasttoday.com/apps/pbcs.dll/article?AID=/20091116/NEWS/911160324" target="_blank"><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo-->Standard Times<!--sizec--></span><!--/sizec--></a><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--> (11/16, Aleem) said Iraq veteran Richard Messier "thought he would not have to worry about paying for college under the Post 9/11 GI Bill," but a "heavy backlog of claims with the Department of Veterans Affairs has created financial problems for the 23-year-old unemployed, full-time undergraduate at Bristol Community College." In September, VA Secretary Eric Shinseki, "announced that 'emergency checks' of $3,000 would be issued to address problems caused by the backlog." Messier "said he had received the emergency payment from the VA office in Providence, 'but that's running out, too.'"<!--sizec--></span><!--/sizec--><a href="http://" target="_blank"></a><b><!--sizeo:3--><span style="font-size:12pt;line-height:100%"><!--/sizeo--> <!--sizec--></span><!--/sizec--></b><a href="http://" target="_blank"></a><b> <br /><br /><br /><a href="http://www.veteranstoday.com/article9455.html" target="_blank">http://www.veteranstoday.com/article9455.html</a></b>]]></description>
		<pubDate>Fri, 20 Nov 2009 03:10:32 -0500</pubDate>
		<guid>http://www.hadit.com/forums/index.php?showtopic=32597</guid>
	</item>
</channel>
</rss>